Search

Your search keyword '"H. Cawston"' showing total 20 results
Start Over Author "H. Cawston" Journal value in health
20 results on '"H. Cawston"'

4. PCN84 Preliminary Results of a Cost Effectiveness MODEL of Atezolizumab PLUS Bevacizumab in Unresectable Hepatocellular Carcinoma (HCC) in France

Author

H. Cawston, B. Mazaleyrat, C. Dubois de Gennes, and J. Sanchez Alvarez

Subjects
Oncology, medicine.medical_specialty, Bevacizumab, business.industry, Cost effectiveness, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, Atezolizumab, Internal medicine, Hepatocellular carcinoma, medicine, business, medicine.drug
Published
2020
Full Text
View/download PDF

7. PUK9 - NETWORK META-ANALYSIS OF TREATMENTS IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL-CELL CARCINOMA WITH INTERMEDIATE TO POOR PROGNOSIS

Author

H Cawston, B Malcolm, J. Doan, V.A. Laliman, X. Wang, and P Dale

Subjects
Oncology, medicine.medical_specialty, Poor prognosis, Renal cell carcinoma, business.industry, Health Policy, Internal medicine, Meta-analysis, Public Health, Environmental and Occupational Health, medicine, medicine.disease, business
Published
2018
Full Text
View/download PDF

8. PRM228 - EXTRAPOLATION OF SURVIVAL CURVES USING EXTERNAL INFORMATION: IMPLEMENTATION OF GUYOT’S METHOD IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMA

Author

H Cawston, B Malcolm, J. Doan, V Genestier, and P Dale

Subjects
0301 basic medicine, medicine.medical_specialty, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Urology, Extrapolation, Guyot, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Renal cell carcinoma, 030220 oncology & carcinogenesis, Medicine, business, Survival analysis
Published
2018
Full Text
View/download PDF

9. PIN61 - COST-EFFECTIVENESS OF ONCE-DAILY DARUNAVIR CONTAINING SINGLE-TABLET REGIMEN (D/C/F/TAF) COMPARED WITH OTHER MULTI-TABLET REGIMENS CONTAINING BOOSTED PROTEASE INHIBITORS (BPIS)

Author

S.C. Bolge, N. Tanova, G. Loriers, U. Sbarigia, H. Cawston, and K. Tronczynski

Subjects
Protease, Cost effectiveness, business.industry, Health Policy, medicine.medical_treatment, Single tablet regimen, Public Health, Environmental and Occupational Health, medicine, Once daily, Pharmacology, business, Darunavir, medicine.drug
Published
2018
Full Text
View/download PDF

10. PRM245 - EXTRAPOLATION OF SURVIVAL IN THE CONTEXT OF ECONOMIC MODELLING USING BAYESIAN MODEL AVERAGING: AN APPLICATION IN RENAL CELL CARCINOMA

Author

B Malcolm, V Genestier, H Cawston, P Dale, and J. Doan

Subjects
Computer science, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Extrapolation, Context (language use), medicine.disease, Machine learning, computer.software_genre, Bayesian inference, Renal cell carcinoma, medicine, Artificial intelligence, business, computer
Published
2018
Full Text
View/download PDF

11. Fixed Combination Netupitant And Palonosetron Is A Cost-Effective Intervention For The Prevention Of Chemotherapy-Induced Nausea And Vomiting In The Uk

Author

Alistair McGuire, P. D'agostino, P. Ruffo, Marco Turini, F. Bourhis, and H Cawston

Subjects
chemistry.chemical_compound, chemistry, business.industry, Intervention (counseling), Anesthesia, Health Policy, Palonosetron, Public Health, Environmental and Occupational Health, Netupitant, Medicine, business, medicine.drug, Chemotherapy-induced nausea and vomiting
Published
2015
Full Text
View/download PDF

12. Cost-Effectiveness of Apremilast In Psoriatic Arthritis In Scotland

Author

H. Cawston, S. Cure, James Morris, F. Zhang, T. Tencer, and F Mughal

Subjects
musculoskeletal diseases, medicine.medical_specialty, Psoriatic arthritis, Cost effectiveness, business.industry, Health Policy, medicine, Public Health, Environmental and Occupational Health, Apremilast, business, medicine.disease, Dermatology, medicine.drug
Published
2015
Full Text
View/download PDF

16. PIN2 ESTIMATED IMPACT OF SUSTAINED VIROLOGICAL RESPONSE (SVR) ON LIFE EXPECTANCY, QUALITY-ADJUSTED LIFE-YEARS (QALYS) AND LIFETIME COSTS IN CHRONIC HEPATITIS C (CHC) PATIENTS

Author

L Dartois, F Bianic, S Cure, H Zhang, and H Cawston

Subjects
Virological response, medicine.medical_specialty, Pediatrics, Chronic hepatitis, business.industry, Health Policy, medicine, Life expectancy, Public Health, Environmental and Occupational Health, business, Surgery, Quality-adjusted life year
Published
2010
Full Text
View/download PDF

18. Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France

Author

H Cawston, G. Pialoux, Audrey Laurisse, A Marcelin, Laurent Finkielsztejn, C. Aubin, and C Guilmet

Subjects
Cost effectiveness, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Human immunodeficiency virus (HIV), Abacavir/Lamivudine, medicine.disease_cause, Virology, Therapy naive, chemistry.chemical_compound, chemistry, Dolutegravir, medicine, business, medicine.drug
Published
2015
Full Text
View/download PDF

19. Cost-Effectiveness of Apremilast In Moderate to Severe Psoriasis In Scotland

Author

F. Zhang, T. Tencer, F Mughal, H Cawston, D Kinahan, and James Morris

Subjects
medicine.medical_specialty, Cost effectiveness, business.industry, Health Policy, Moderate to severe psoriasis, Public Health, Environmental and Occupational Health, medicine, Apremilast, business, Dermatology, health care economics and organizations, medicine.drug
Published
2015
Full Text
View/download PDF

20. PIN4 IMPACT OF SUSTAINED VIROLOGICAL RESPONSE (SVR) ON LIFE EXPECTANCY AND QUALITY-ADJUSTED LIFE-YEARS (QALYS) IN CHRONIC HEPATITIS C (CHC) PATIENTS

Author

S Cure, L Dartois, F Bianic, H Cawston, and H Zhang

Subjects
Virological response, medicine.medical_specialty, Pediatrics, Chronic hepatitis, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Life expectancy, Medicine, business, Surgery, Quality-adjusted life year
Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results